Skip to content

    IONIS PHARMACEUTICALS (IONS) stock price & financials

    View IONS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+42.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $133.81M
    $226.58M
    $131.61M
    $452.05M
    $156.72M
    +17.1%
    $203.33M
    -10.3%
    $246.09M
    +87.0%
    $267.95M
    -40.7%
    Strengthening
    Operating Profit
    -$148.66M
    -$110.82M
    -$146.86M
    $139.82M
    -$160.18M
    -7.8%
    -$214.46M
    -93.5%
    -$117.42M
    +20.0%
    -$102.29M
    -173.2%
    Weakening
    Net Profit
    -$140.48M
    -$104.35M
    -$146.94M
    $123.55M
    -$128.61M
    +8.5%
    -$229.39M
    -119.8%
    -$92.53M
    +37.0%
    -$114.65M
    -192.8%
    Weakening
    EPS
    $-0.95
    $-0.66
    $-0.93
    $0.78
    $-0.80
    +15.8%
    $-1.41
    -113.6%
    $-0.56
    +39.8%
    $-0.69
    -188.5%
    Weakening
    Other Income
    Interest
    $4.16M
    $4.19M
    $4.11M
    $4.11M
    $4.21M
    +1.2%
    $4.83M
    +15.2%
    $5.16M
    +25.6%
    $4.62M
    +12.3%
    Strengthening
    Depreciation
    Profit before Tax
    -$144.10M
    -$107.04M
    -$146.82M
    $123.53M
    -$128.39M
    +10.9%
    -$227.92M
    -112.9%
    -$92.31M
    +37.1%
    -$113.38M
    -191.8%
    Weakening
    MarginsOPM
    -111.1%
    -48.9%
    -111.6%
    30.9%
    -102.2%
    +8.0%
    -105.5%
    -115.6%
    -47.7%
    +57.2%
    -38.2%
    -223.4%
    Weakening
    Tax
    2.5%
    2.5%
    -0.1%
    -0.0%
    -0.2%
    -106.8%
    -0.7%
    -125.9%
    -0.2%
    -200.0%
    -1.1%
    -5450.0%
    Weakening
    ReturnsROIC
    4.9%
    3.7%
    5.2%
    -4.4%
    4.5%
    -8.5%
    8.1%
    +119.8%
    3.3%
    -37.0%
    4.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$278.82M$683.29M$397.66M$869.19M$276.47M$399.27M$242.08M$372.26M$350.06M
    Short-Term Investments
    Total Current Assets$2.21B$2.72B$2.13B$2.35B$2.20B$2.64B$2.62B$2.99B$2.49B
    Net PP&E$132.16M$166.25M$194.18M$196.04M$255.84M$242.94M$256.11M$361.60M$386.69M
    Goodwill
    Intangibles$24.03M$25.67M$27.94M$29.00M
    Total Assets$2.67B$3.23B$2.39B$2.61B$2.53B$2.99B$3.00B$3.52B$2.99B
    LiabilitiesTotal Current Liabilities$280.29M$273.00M$598.90M$240.55M$311.56M$448.09M$309.32M$781.57M$315.64M
    Short-Term Debt$151.0K$157.0K$165.0K$432.12M
    Long-Term Debt$1.18B$1.24B$1.20B$1.33B
    Long-Term Leases$19.43M$178.94M$170.88M$161.81M$262.38M$262.48M
    Total Liabilities$1.48B$1.55B$1.65B$1.84B$1.96B$2.60B$2.42B$3.03B$2.55B
    EquityCommon Stock & APIC$138.0K$140.0K$140.0K$141.0K$142.0K$144.0K$158.0K$163.0K$166.0K
    Retained Earnings-$967.29M-$707.53M-$1.13B-$1.16B-$1.43B-$1.80B-$2.25B-$2.63B-$2.84B
    Total Equity$1.05B$1.47B$743.28M$771.74M$572.89M$386.69M$588.35M$489.09M$439.74M
    HighlightsNet Cash / (Debt)-$899.40M-$841.89M-$960.49M-$1.39B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$602.91M$345.63M$35.89M$30.80M-$274.37M-$307.51M-$500.95M-$268.58M-$496.43M
    Cash from Investing-$929.56M-$41.27M$274.48M$194.91M-$262.64M-$214.13M-$134.03M-$277.78M$232.15M
    Cash from Financing$475.87M$100.02M-$596.61M$245.93M-$55.30M$644.08M$478.06M$675.84M$317.36M
    SummaryCapital Expenditure-$13.61M-$30.91M-$35.12M-$11.96M-$15.72M-$23.80M-$45.28M-$51.44M-$64.41M
    Free Cash Flow$589.30M$314.72M$772.0K$18.84M-$290.09M-$331.32M-$546.23M-$320.03M-$560.84M
    FCF Margin98.3%28.0%0.1%2.3%-49.4%-42.1%-77.5%-33.9%-64.2%

    Ratios